These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7739798)

  • 1. Reduced and oxidized forms of glutathione and alpha-tocopherol in the cerebrospinal fluid of parkinsonian patients: comparison between before and after L-dopa treatment.
    Tohgi H; Abe T; Saheki M; Hamato F; Sasaki K; Takahashi S
    Neurosci Lett; 1995 Jan; 184(1):21-4. PubMed ID: 7739798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia.
    Tohgi H; Abe T; Nakanishi M; Hamato F; Sasaki K; Takahashi S
    Neurosci Lett; 1994 Jun; 174(1):73-6. PubMed ID: 7970159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Tocopherol quinone level is remarkably low in the cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.
    Tohgi H; Abe T; Saheki M; Yamazaki K; Takahashi S
    Neurosci Lett; 1996 Mar; 207(1):5-8. PubMed ID: 8710208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E.
    Adams JD; Klaidman LK; Odunze IN; Shen HC; Miller CA
    Mol Chem Neuropathol; 1991 Jun; 14(3):213-26. PubMed ID: 1958264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson's disease.
    Isobe C; Abe T; Terayama Y
    J Clin Neurosci; 2010 Jun; 17(6):717-21. PubMed ID: 20356746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease.
    Molina JA; de Bustos F; Jiménez-Jiménez FJ; Benito-León J; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Navarro JA; Arenas J; Enríquez-de-Salamanca R
    J Neural Transm (Vienna); 1997; 104(11-12):1287-93. PubMed ID: 9503274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases.
    Maetzler W; Schmid SP; Wurster I; Liepelt I; Gaenslen A; Gasser T; Berg D
    Mov Disord; 2011 Jan; 26(1):176-81. PubMed ID: 20842692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Hamato H
    Neurosci Lett; 1993 Sep; 159(1-2):135-8. PubMed ID: 7505410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: implications for therapy of Parkinson's disease.
    Sabens EA; Distler AM; Mieyal JJ
    Biochemistry; 2010 Mar; 49(12):2715-24. PubMed ID: 20141169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized vitamin E and glutathione as markers of clinical status in asthma.
    Wood LG; Garg ML; Blake RJ; Simpson JL; Gibson PG
    Clin Nutr; 2008 Aug; 27(4):579-86. PubMed ID: 18234400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure of striatal [corrected] synaptosomes to L-dopa increases levels of oxidized glutathione.
    Spina MB; Cohen G
    J Pharmacol Exp Ther; 1988 Nov; 247(2):502-7. PubMed ID: 3183949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
    Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
    J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal cocaine administration increases glutathione and alpha-tocopherol oxidation in fetal rat brain.
    Lipton JW; Gyawali S; Borys ED; Koprich JB; Ptaszny M; McGuire SO
    Brain Res Dev Brain Res; 2003 Dec; 147(1-2):77-84. PubMed ID: 14741753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione disulfide enhances the reduced glutathione inhibition of lipid peroxidation in rat liver microsomes.
    Scholz RW; Graham KS; Reddy CC
    Biochem Biophys Res Commun; 1990 Jan; 166(2):960-6. PubMed ID: 2302250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson's disease.
    Spencer JP; Jenner P; Halliwell B
    Neuroreport; 1995 Jul; 6(11):1480-4. PubMed ID: 7579129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of 3-O-methyldopa concentrations in the cerebrospinal fluid in the pathogenesis of wearing-off phenomenon in Parkinson's disease.
    Tohgi H; Abe T; Kikuchi T; Takahashi S; Nozaki Y
    Neurosci Lett; 1991 Oct; 132(1):19-22. PubMed ID: 1787913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No reduction of alpha-tocopherol quinone by glutathione in rat liver microsomes.
    van Haaften RI; Evelo CT; Haenen GR; Bast A
    Biochem Pharmacol; 2001 Mar; 61(6):715-9. PubMed ID: 11266656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels.
    Pappert EJ; Tangney CC; Goetz CG; Ling ZD; Lipton JW; Stebbins GT; Carvey PM
    Neurology; 1996 Oct; 47(4):1037-42. PubMed ID: 8857741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson's and other dopamine deficiency states.
    Allen GF; Ullah Y; Hargreaves IP; Land JM; Heales SJ
    Neurochem Int; 2013 Apr; 62(5):684-94. PubMed ID: 23261515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.